Search Results for: Un farmaco per il diabete potrebbe curare l’Alzheimer.

Buildup of the protein amyloid β (Aβ) in the brain can predict Alzheimer disease years before symptoms appear. Although learning about the risk may relieve some anxiety, a new study suggests that it lessens individuals’ motivation to maintain a healthy lifestyle.

This Special Communication presents a framework for using a cross-species behavioral neuroscience approach to study emotional well-being and brain aging in the context of Alzheimer disease and related dementias.

Inaugurata al al Centro Antiveleni di Maugeri

Niente più visita specialistica per il rinnovo dei Piani terapeutici da fare ogni 6-12 mesi e soprattutto la possibilità di trovare il farmaco di cui si ha bisogno nella farmacia…

Positività 0,97% e 2,8%, ma va confermata. Verso test nazionale

Positività 0,97% e 2,8%, ma va confermata. Verso test nazionale

Introduction
Cognitive frailty (CF) is a clinical syndrome characterised by the concurrent occurrence of physical frailty and cognitive impairment, excluding Alzheimer’s disease and other forms of dementia. Recent studies have shown that combining aerobic exercise (AE) and meditation (ME) effectively enhances both physical and cognitive functions in individuals with CF. The study aims to determine whether the combined application of AE and ME can elicit significantly greater improvements in physical and cognitive functions among individuals with CF compared with the independent practice of either AE or ME alone.

Methods and analysis
The research design employs a four-arm, assessor-blind randomised controlled trial. A total of 140 qualified subjects will be randomly allocated among four groups: AE, ME, AE combined with ME and a health education control group, ensuring equivalent distribution across groups. The intervention phase of the study will last for 12 weeks. The primary outcomes will include the Edmonton Frailty Scale, while secondary outcomes will encompass evaluations of cognitive functions (including global cognitive function, memory, attention, executive function and visuospatial abilities), physical performance (measured by gait speed and lower extremity strength), subjective experiences (such as fatigue, quality of life, mindfulness, mood and sleep quality), as well as structural and functional MRI assessments and serum biomarkers. Outcomes will be evaluated at baseline and following the 12-week intervention.

Ethics and dissemination
The Ethics Committee of the Affiliated Rehabilitation Hospital of the Fujian University of Traditional Chinese Medicine granted ethical approval for the study (2023KY-012–02). The findings will be disseminated through publications in peer-reviewed journals and presentations at academic conferences.

Trial registration number
ChiCTR2300073563.

Risultati incoraggianti da studio fase 3 su sotatercept

A base di cellule pancreatiche derivate da staminali, studio 1/2

Screening della popolazione pediatrica. Il diabete è simile ai paesi Ue

Atrofia muscolare spinale, risultati positivi da studio fase 1

Potrebbe sembrare fantascienza, ma è medicina sperimentale con basi molto concrete: 10 persone affette da diabete di tipo 1 non hanno più bisogno di iniettarsi insulina da oltre un anno,…

Elacestrant, appena approvato da AIFA. Studio IEO di Milano

Gli attacchi di emicrania si possono curare e anche prevenire in maniera sempre più efficace. Tra le più innovative terapie da assumere per evitarne l’insorgenza, ci sono i farmaci che…

Farmaco rivoluziona prevenzione. Salgono contagi ma taglio fondi